Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Aprea Therapeutics (APRE) Q2 2025 Earnings
APRE
14
May
Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.72
-0.64
-0.57
-0.49
Details
Expected EPS
-0.6543
Actual EPS
-0.66
Surprise EPS
-0.01
Surprise Percent
+0.87%
Description
Aprea Therapeutics (APRE) has reported earnings of -0.66 per share for Q2 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login